{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:midazolam-hydrochloride-injection",
  "slug": "midazolam-hydrochloride-injection",
  "title": "FDA shortage status: Midazolam Hydrochloride Injection",
  "ingredient": "Midazolam Hydrochloride Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "MIDAZOLAM",
    "MIDAZOLAM HYDROCHLORIDE",
    "MIDAZOLAM IN SODIUM CHLORIDE"
  ],
  "therapeutic_categories": [
    "Anesthesia",
    "Neurology"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS"
  ],
  "package_count": 26,
  "packages": [
    {
      "package_ndc": "23155-600-41",
      "product_ndc": "23155-600",
      "company_name": "Avet Pharmaceuticals, Inc.",
      "manufacturer_name": "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "23155-601-41",
      "product_ndc": "23155-601",
      "company_name": "Avet Pharmaceuticals, Inc.",
      "manufacturer_name": "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "23155-601-42",
      "product_ndc": "23155-601",
      "company_name": "Avet Pharmaceuticals, Inc.",
      "manufacturer_name": "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-211-20",
      "product_ndc": "76045-001",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-411-10",
      "product_ndc": "63323-411",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-411-12",
      "product_ndc": "63323-411",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-411-25",
      "product_ndc": "63323-411",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-412-02",
      "product_ndc": "63323-411",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-412-10",
      "product_ndc": "63323-411",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-412-25",
      "product_ndc": "63323-411",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-655-02",
      "product_ndc": "25021-655",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-661-10",
      "product_ndc": "25021-661",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6056-10",
      "product_ndc": "0641-6056",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6057-25",
      "product_ndc": "0641-6056",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6059-01",
      "product_ndc": "0641-6056",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6060-10",
      "product_ndc": "0641-6056",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6061-25",
      "product_ndc": "0641-6056",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2308-02",
      "product_ndc": "0409-0001",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2305-17",
      "product_ndc": "0409-0001",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2305-05",
      "product_ndc": "0409-0001",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2308-01",
      "product_ndc": "0409-0001",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2587-05",
      "product_ndc": "0409-2587",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2596-03",
      "product_ndc": "0409-2587",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2596-05",
      "product_ndc": "0409-2587",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "44567-610-10",
      "product_ndc": "44567-610",
      "company_name": "WG Critical Care",
      "manufacturer_name": "WG Critical Care, LLC.",
      "presentation": "Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "44567-611-10",
      "product_ndc": "44567-610",
      "company_name": "WG Critical Care",
      "manufacturer_name": "WG Critical Care, LLC.",
      "presentation": "Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/02/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 15,
    "Limited Availability": 2,
    "Unavailable": 9
  },
  "initial_posting_date": "04/02/2020",
  "latest_source_update": "08/18/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}